Concomitant hyperfractionated accelerated radiotherapy (HART) with cisplatin and concurrent cetuximab for locoregionally advanced squamous cell head and neck cancer: a phase I dose escalation trialThomas Kuhnt, Juergen Dunst, Guido Lammering et al.|Journal of Clinical Oncology|2008Cited by 6
OC-0293 TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trialEmmanouil Fokas, Claus Rödel, Anke Schlenska‐Lange et al.|Radiotherapy and Oncology|2021Cited by 0